Figure 2From: Interleukin-6 and rheumatic diseasesTherapeutic efficacy of blocking IL-6 activity in sJIA. IL, interleukin; sJIA, systemic onset juvenile idiopathic arthritis. Reprinted, with permission, from [19]. Copyright © 2005 American College of Rheumatology.Back to article page